4//SEC Filing
Wigzell Hans Lennart Rudolf 4
Accession 0001209191-21-019670
CIK 0000873303other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 8:03 PM ET
Size
9.0 KB
Accession
0001209191-21-019670
Insider Transaction Report
Form 4
Wigzell Hans Lennart Rudolf
Director
Transactions
- Exercise/Conversion
Common Stock
2021-03-08$34.92/sh+10,000$349,200→ 26,518 total - Sale
Common Stock
2021-03-08$83.51/sh−10,000$835,100→ 16,518 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-08−10,000→ 0 totalExercise: $34.92From: 2014-06-04Exp: 2023-06-04→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares were sold in transactions at prices ranging from 83.33 to 83.91, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001492766
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 8:03 PM ET
- Size
- 9.0 KB